About
Johnson & Johnson Innovation (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Its portfolio companies benefit from the full global capabilities of Johnson & Johnson as JJDC collaborates to drive innovation. JJDC finds transformative ideas and helps them mature into real solutions for todays patients. Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations. JJDC invests across sectorspharmaceuticals, medical devices, and consumer healthcareand at all stages, from seed-level startups to Series B and beyond. JJDC also makes private investments in public equity. All of its portfolio companies receive the same unwavering commitment. JJDC takes a long-term approach, deploying the full capabilities of the Johnson & Johnson family of companies, including discovery, clinical development, regulatory affairs, manufacturing and commercialization. JJDC's team includes leaders in the healthcare and technology communities, many with deep R&D experience.
Portfolio · 13
Investment activity
6 portfolio exits on record.
Portfolio by sector
Q&A
- What is Johnson & Johnson Innovation's primary investment focus?
- Johnson & Johnson Innovation primarily focuses on the Health Tech & Life Sciences sector, with all 15 of its portfolio companies operating in this area.
- Can you name some of Johnson & Johnson Innovation's recent exits?
- In August 2024, Johnson & Johnson Innovation saw the acquisition of V-Wave for $600M. In May 2022, CartiHeal was acquired by Bioventus.
- What is Johnson & Johnson Innovation's investment stage preference?
- Johnson & Johnson Innovation invests across various stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- Which notable companies are in Johnson & Johnson Innovation's current portfolio?
- Key companies in Johnson & Johnson Innovation's portfolio include BiomX, which focuses on microbiome therapies, and DayTwo, specializing in precision nutrition for metabolic disease.
- What was a significant exit for Johnson & Johnson Innovation in 2021?
- In August 2021, Zebra Medical Vision, an AI-based medical imaging solutions company, was acquired by Nanox Vision for $200M.
- How many investment rounds has Johnson & Johnson Innovation participated in within the last two years?
- Johnson & Johnson Innovation participated in one investment round in March 2022 and another in October 2024.
- What is the typical check size for Johnson & Johnson Innovation?
- Johnson & Johnson Innovation's investment range is between $2.25M and $98M.
- Who are some of the key team members at Johnson & Johnson Innovation?
- The team includes Zeev Zehavi and VP Venture Investments.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | jnjinnovation.com/jjdc |
|---|
Identifiers & details
| Founded | 1973 |
|---|
Radar intelligence
Patents
| EPO | 40 |
|---|
Web history (Wayback)
| Domain | jnjinnovation.com |
|---|
Certificate / subdomain footprint
| Subdomains | 56 |
|---|